CD8A and autoimmune thrombocytopenic purpura: Nonetheless, 20% of patients with ITP have no clinically detectable autoantibodies, indicating that, at least for a subgroup of patients, autoantibody-independent pathways such as platelet destruction by CD8+ cytotoxic T cells are involved [1,2,3,6,8,9].